Pancreatic Cancer Research

ResearcherKindai University HospitalNo recent work listed

Atsushi Nakai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0569-3948; OpenAlex author ID A5101428988. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomiz… Co-author DOI 10.1002/jgh3.12966↗
  2. Utility of contrast-enhanced harmonic EUS for diagnosis of portal vein invasion by pancreatic cancer. Co-author DOI 10.4103/eus-d-21-00185↗
  3. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video). Co-author DOI 10.1016/j.gie.2020.06.051↗
  4. Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Loca… Co-author DOI 10.3390/diagnostics10070445↗
  5. Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.dld.2019.03.015↗
  6. Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrosp… Co-author DOI 10.2169/internalmedicine.2234-18↗
  7. Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis. Co-author DOI 10.3390/cancers10020050↗
  8. Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1159/000481234↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kosuke Minaga · 8 shared papers, 2017–2023 · strength 0.74
  2. Mamoru Takenaka · 8 shared papers, 2017–2023 · strength 0.74
  3. Ken Kamata · 8 shared papers, 2017–2023 · strength 0.74
  4. Kentaro Yamao · 8 shared papers, 2017–2023 · strength 0.74
  5. Masatoshi Kudo · 8 shared papers, 2017–2023 · strength 0.74
  6. Masayuki Kitano · 4 shared papers, 2018–2023 · strength 0.40
  7. Ippei Matsumoto · 4 shared papers, 2017–2022 · strength 0.38
  8. Yoshifumi Takeyama · 3 shared papers, 2017–2022 · strength 0.26
  9. Masakatsu Tsurusaki · 2 shared papers, 2020–2021 · strength 0.21
  10. Hidekazu Tanaka · 2 shared papers, 2019–2022 · strength 0.20
  11. Yukitaka Yamashita · 1 shared paper, 2023 · strength 0.13
  12. Yasuo Otsuka · 1 shared paper, 2022 · strength 0.12
  13. Hiroki Sakamoto · 1 shared paper, 2018 · strength 0.07
  14. Tomohiro Matsuda · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.